BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 24393203)

  • 21. [Regulation of NF-kappaB/P65 by MDM2 in acute lymphoblastic leukemia in childhood].
    Hu Q; Zhou MX; Liu SY; Zhang LQ; Liu AQ; Guo YJ; Song Y
    Zhonghua Er Ke Za Zhi; 2003 Dec; 41(12):921-4. PubMed ID: 14723816
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bone marrow stromal cells and the upregulation of interleukin-8 production in human T-cell acute lymphoblastic leukemia through the CXCL12/CXCR4 axis and the NF-kappaB and JNK/AP-1 pathways.
    Scupoli MT; Donadelli M; Cioffi F; Rossi M; Perbellini O; Malpeli G; Corbioli S; Vinante F; Krampera M; Palmieri M; Scarpa A; Ariola C; Foà R; Pizzolo G
    Haematologica; 2008 Apr; 93(4):524-32. PubMed ID: 18322253
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel mechanism for CTCF in the epigenetic regulation of Bax in breast cancer cells.
    Méndez-Catalá CF; Gretton S; Vostrov A; Pugacheva E; Farrar D; Ito Y; Docquier F; Kita GX; Murrell A; Lobanenkov V; Klenova E
    Neoplasia; 2013 Aug; 15(8):898-912. PubMed ID: 23908591
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epidermal growth factor (EGF)-induced corneal epithelial wound healing through nuclear factor κB subtype-regulated CCCTC binding factor (CTCF) activation.
    Wang L; Wu X; Shi T; Lu L
    J Biol Chem; 2013 Aug; 288(34):24363-71. PubMed ID: 23843455
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel pathway links oxidative stress to loss of insulin growth factor-2 (IGF2) imprinting through NF-κB activation.
    Yang B; Wagner J; Damaschke N; Yao T; Wuerzberger-Davis SM; Lee MH; Svaren J; Miyamoto S; Jarrard DF
    PLoS One; 2014; 9(2):e88052. PubMed ID: 24558376
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevention of etoposide-induced apoptosis by proteasome inhibitors in a human leukemic cell line but not in fresh acute leukemia blasts. A differential role of NF-kappab activation.
    Watanabe K; Kubota M; Hamahata K; Lin Y; Usami I
    Biochem Pharmacol; 2000 Sep; 60(6):823-30. PubMed ID: 10930537
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SLUG is activated by nuclear factor kappa B and confers human alveolar epithelial A549 cells resistance to tumor necrosis factor-alpha-induced apoptosis.
    Wang Y; Yue B; Yu X; Wang Z; Wang M
    World J Surg Oncol; 2013 Jan; 11():12. PubMed ID: 23339680
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Nedd8-activating enzyme inhibitor MLN4924 thwarts microenvironment-driven NF-κB activation and induces apoptosis in chronic lymphocytic leukemia B cells.
    Godbersen JC; Humphries LA; Danilova OV; Kebbekus PE; Brown JR; Eastman A; Danilov AV
    Clin Cancer Res; 2014 Mar; 20(6):1576-89. PubMed ID: 24634471
    [TBL] [Abstract][Full Text] [Related]  

  • 29. NF kappa B controls the balance between Fas and tumor necrosis factor cell death pathways during T cell receptor-induced apoptosis via the expression of its target gene A20.
    Malewicz M; Zeller N; Yilmaz ZB; Weih F
    J Biol Chem; 2003 Aug; 278(35):32825-33. PubMed ID: 12813034
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cyr61 decreases Cytarabine chemosensitivity in acute lymphoblastic leukemia cells via NF-κB pathway activation.
    Cao Y; Wu C; Song Y; Lin Z; Kang Y; Lu P; Zhang C; Huang Q; Hao T; Zhu X; Hu J
    Int J Mol Med; 2019 Feb; 43(2):1011-1020. PubMed ID: 30535449
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bioimaging analysis of nuclear factor-κB activity in Philadelphia chromosome-positive acute lymphoblastic leukemia cells reveals its synergistic upregulation by tumor necrosis factor-α-stimulated changes to the microenvironment.
    Tsai HJ; Kobayashi S; Izawa K; Ishida T; Watanabe T; Umezawa K; Lin SF; Tojo A
    Cancer Sci; 2011 Nov; 102(11):2014-21. PubMed ID: 21777350
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glycogen Synthase Kinase-3β (GSK-3β) and Nuclear Factor Kappa-B (NFKB) in Childhood Acute Lymphoblastic Leukemia.
    Tovar CF; Zerón HM; Romero MD; Sánchez YV; Romero IT
    Adv Clin Exp Med; 2016; 25(6):1139-1147. PubMed ID: 28028966
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Amyloid precursor protein cooperates with c-KIT mutation/overexpression to regulate cell apoptosis in AML1-ETO-positive leukemia via the PI3K/AKT signaling pathway.
    Yu G; Yin C; Jiang L; Zheng Z; Wang Z; Wang C; Zhou H; Jiang X; Liu Q; Meng F
    Oncol Rep; 2016 Sep; 36(3):1626-32. PubMed ID: 27460334
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The notch pathway promotes NF-κB activation through Asb2 in T cell acute lymphoblastic leukemia cells.
    Wu W; Nie L; Zhang L; Li Y
    Cell Mol Biol Lett; 2018; 23():37. PubMed ID: 30116272
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Loss of miR-146b-5p promotes T cell acute lymphoblastic leukemia migration and invasion via the IL-17A pathway.
    Tu Z; Xiong J; Xiao R; Shao L; Yang X; Zhou L; Yuan W; Wang M; Yin Q; Wu Y; Pan S; Leng J; Jiang D; He C; Zhang Q
    J Cell Biochem; 2019 Apr; 120(4):5936-5948. PubMed ID: 30362152
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of c-REL using siRNA increased apoptosis and decreased proliferation in pre-B ALL blasts: Therapeutic implications.
    Mohammadi SM; Mohammadnejad D; Hosseinpour Feizi AA; Movassaghpour AA; Montazersaheb S; Nozad Charoudeh H
    Leuk Res; 2017 Oct; 61():53-61. PubMed ID: 28892661
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cyr61 participates in the pathogenesis of acute lymphoblastic leukemia by enhancing cellular survival via the AKT/NF-κB signaling pathway.
    Zhu X; Song Y; Wu C; Pan C; Lu P; Wang M; Zheng P; Huo R; Zhang C; Li W; Lin Y; Cao Y; Li N
    Sci Rep; 2016 Oct; 6():34018. PubMed ID: 27725691
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Functional role of CCCTC binding factor in insulin-stimulated cell proliferation.
    Gao J; Li T; Lu L
    Cell Prolif; 2007 Dec; 40(6):795-808. PubMed ID: 18021171
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Src, Akt, NF-κB, BCL-2 and c-IAP1 may be involved in an anti-apoptotic effect in patients with BCR-ABL positive and BCR-ABL negative acute lymphoblastic leukemia.
    Vázquez-Franco JE; Reyes-Maldonado E; Vela-Ojeda J; Domínguez-López ML; Lezama RA
    Leuk Res; 2012 Jul; 36(7):862-7. PubMed ID: 22591684
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The IKK2/NF-{kappa}B pathway suppresses MYC-induced lymphomagenesis.
    Klapproth K; Sander S; Marinkovic D; Baumann B; Wirth T
    Blood; 2009 Sep; 114(12):2448-58. PubMed ID: 19628709
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.